Fingerprint
Dive into the research topics of 'A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254
Richard R. Furman, Michael L. Grossbard, Jeffrey L. Johnson, Andrew L. Pecora, Peter A. Cassileth, Sin Ho Jung, Bruce A Peterson, Lee M. Nadler, Arnold Freedman, Ruthee Lu Bayer, Nancy L. Bartlett, David D. Hurd, Bruce D. Cheson
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations